RAPT Rapt Therapeutics2.27+0.08 (+3.7%)
Premarket Decliner
RAPT Rapt Therapeutics7.98-0.10-1.2%
Premarket:6.01-1.97 (-24.7%)
RAPT Therapeutics Reports First Quarter 2024 Financial Results
Globe NewswireThu, 9-May 8:00 AM
RAPT Rapt Therapeutics8.64-0.04 (-0.5%)
RAPT Rapt Therapeutics8.78+1.91 (+27.8%)
RAPT Rapt Therapeutics7.47-18.50 (-71.2%)
Premarket Decliner
RAPT Rapt Therapeutics25.97+0.43+1.7%
Premarket:8.49-17.48 (-67.3%)
RAPT Therapeutics Announces Clinical Hold on Studies Evaluating Zelnecirnon
Globe NewswireTue, 20-Feb 7:30 AM